190 related articles for article (PubMed ID: 29026148)
1. Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study.
Archibugi L; Piciucchi M; Stigliano S; Valente R; Zerboni G; Barucca V; Milella M; Maisonneuve P; Delle Fave G; Capurso G
Sci Rep; 2017 Oct; 7(1):13024. PubMed ID: 29026148
[TBL] [Abstract][Full Text] [Related]
2. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
3. The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom.
Carey FJ; Little MW; Pugh TF; Ndokera R; Ing H; Clark A; Dennison A; Metcalfe MS; Robinson RJ; Hart AR
Dig Dis Sci; 2013 Nov; 58(11):3308-12. PubMed ID: 23864194
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Use and Risk of Pancreatic Ductal Adenocarcinoma: A Large Case-Control Study.
Momayez Sanat Z; Masoudi S; Tabaeian SP; Jameh Shorani M; Soruri M; Pourshams A
Arch Iran Med; 2023 Apr; 26(4):181-185. PubMed ID: 38301077
[TBL] [Abstract][Full Text] [Related]
5. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
Beales IL; Vardi I; Dearman L; Broughton T
Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
[TBL] [Abstract][Full Text] [Related]
6. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
7. Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma.
Beales IL; Vardi I; Dearman L
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):917-23. PubMed ID: 22569083
[TBL] [Abstract][Full Text] [Related]
8. Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.
Beales IL; Dearman L; Vardi I; Loke Y
Dig Dis Sci; 2016 Jan; 61(1):238-46. PubMed ID: 26386857
[TBL] [Abstract][Full Text] [Related]
9. The effect of statins on the occurrence of peptic ulcer.
Feng A; Chuang E; Wu SH; Wang JC; Chang SN; Lin CL; Kao CH
Eur J Intern Med; 2015 Nov; 26(9):731-5. PubMed ID: 26226858
[TBL] [Abstract][Full Text] [Related]
10. Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis.
Archibugi L; Arcidiacono PG; Capurso G
Dig Liver Dis; 2019 Jan; 51(1):28-37. PubMed ID: 30314951
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study.
Kho PF; Fawcett J; Fritschi L; Risch H; Webb PM; Whiteman DC; Neale RE
Cancer Causes Control; 2016 Dec; 27(12):1457-1464. PubMed ID: 27817122
[TBL] [Abstract][Full Text] [Related]
12. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.
Lafeber M; Spiering W; van der Graaf Y; Nathoe H; Bots ML; Grobbee DE; Visseren FL
Am Heart J; 2013 Aug; 166(2):282-289.e1. PubMed ID: 23895811
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma.
Liebow M; Larson MC; Thompson CA; Nowakowski GS; Call TG; Macon WR; Kay NE; Habermann TM; Slager SL; Cerhan JR
Int J Cancer; 2021 Aug; 149(3):535-545. PubMed ID: 33644854
[TBL] [Abstract][Full Text] [Related]
14. Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis.
Tamburrino D; Crippa S; Partelli S; Archibugi L; Arcidiacono PG; Falconi M; Capurso G
Dig Liver Dis; 2020 Apr; 52(4):392-399. PubMed ID: 32113888
[TBL] [Abstract][Full Text] [Related]
15. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
16. Do statins protect against upper gastrointestinal bleeding?
Gulmez SE; Lassen AT; Aalykke C; Dall M; Andries A; Andersen BS; Hansen JM; Andersen M; Hallas J
Br J Clin Pharmacol; 2009 Apr; 67(4):460-5. PubMed ID: 19371320
[TBL] [Abstract][Full Text] [Related]
17. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.
Walker EJ; Ko AH; Holly EA; Bracci PM
Cancer; 2015 Apr; 121(8):1287-94. PubMed ID: 25649483
[TBL] [Abstract][Full Text] [Related]
18. Statin use and risk of pancreatic cancer: a meta-analysis.
Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
[TBL] [Abstract][Full Text] [Related]
19. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
[TBL] [Abstract][Full Text] [Related]
20. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study.
Hoffmeister M; Chang-Claude J; Brenner H
Int J Cancer; 2007 Sep; 121(6):1325-30. PubMed ID: 17487832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]